On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Azienda Ospedaliera Treviglio

InstitutionResearch output, impact & collaborations

Azienda Ospedaliera Treviglio is a institution indexed in ScholarIQ from OpenAlex.

What is known about Azienda Ospedaliera Treviglio?

ScholarIQrecord summary

Azienda Ospedaliera Treviglio is a research organisation in Treviglio, IT. OpenAlex records 1,334 works and 102,682 citations for it. 326 researchers list it as their most recent affiliation.

How many works does Azienda Ospedaliera Treviglio have?

ScholarIQindexed works

Azienda Ospedaliera Treviglio has 1,334 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Azienda Ospedaliera Treviglio have?

ScholarIQcitation count

Azienda Ospedaliera Treviglio has 102,682 citations in the OpenAlex counts ScholarIQ stores.

How many researchers are at Azienda Ospedaliera Treviglio?

ScholarIQresearcher count

Azienda Ospedaliera Treviglio has 326 researchers in the ScholarIQ index.

What is the average h-index at Azienda Ospedaliera Treviglio?

ScholarIQavg h-index

Azienda Ospedaliera Treviglio has an average h-index of 77 in OpenAlex.

What is the ROR of Azienda Ospedaliera Treviglio?

ScholarIQror

The ROR for Azienda Ospedaliera Treviglio is on the source record.

What is the OpenAlex record for Azienda Ospedaliera Treviglio?

ScholarIQopenalex

The OpenAlex for Azienda Ospedaliera Treviglio is on the source record.

Who are the most-cited researchers behind Azienda Ospedaliera Treviglio?

ScholarIQtop researchers by citations
1
Sandro Barni · Cancer Treatment and Pharmacology
780 works23,725 citations

What are the most-cited papers on Azienda Ospedaliera Treviglio?

ScholarIQmost cited works
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study
Giancarlo Agnelli, Gualberto Gussoni, C. Bianchini, Melina Verso, Mario Mandalà, Luigi Cavanna, Sandro Barni, Roberto Labianca, Franco Buzzi, Giovanni Scambia, Rodolfo Passalacqua, Sergio Ricci, Giampietro Gasparini, Vito Lorusso, Erminio Bonizzoni, Maurizio Tonato
The Lancet Oncology. 2009599 Citations
FOLFOXIRI Plus Bevacizumab as Conversion Therapy for Patients With Initially Unresectable Metastatic Colorectal Cancer
Gianluca Tomasello, Fausto Petrelli, Michele Ghidini, Alessandro Russo, Rodolfo Passalacqua, Sandro Barni
JAMA Oncology. 2017206 CitationsOPEN ACCESS

How much of the research on Azienda Ospedaliera Treviglio is open access?

ScholarIQopen access share
50%OPEN ACCESS
Gold
0%
Green
50%
Hybrid
0%
Bronze
0%
Closed
50%

Related on ScholarIQ

470M+ articles · 14-day free trial